| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CDXS | Common Stock | Sale | $270,238 | -39,786 | -4.2% | $6.79 | 903,320 | 15 Nov 2022 | Direct | F1, F2 |
| transaction | CDXS | Common Stock | Options Exercise | $70,357 | +35,714 | +4% | $1.97 | 939,034 | 16 Nov 2022 | Direct | F1 |
| transaction | CDXS | Common Stock | Sale | $227,312 | -35,714 | -3.8% | $6.36 | 903,320 | 16 Nov 2022 | Direct | F1, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CDXS | Stock Option (Right to Buy) | Options Exercise | $0 | -35,714 | -8.3% | $0.000000 | 392,854 | 16 Nov 2022 | Common Stock | 35,714 | $1.97 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 31, 2022. |
| F2 | This transaction was executed in multiple trades in prices ranging from $6.64 to $6.87, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F3 | This transaction was executed in multiple trades in prices ranging from $6.175 to $6.68, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |